OptimizeRx Corporation (OPRX)
4.86
0.01 (0.21%)
At close: Jan 14, 2025, 3:59 PM
4.87
0.10%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 4.75 |
| Market Cap | 89.53M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.34 |
| PE Ratio (ttm) | -3.63 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 6.5 |
| Volume | 82,726 |
| Avg. Volume (20D) | 308,263 |
| Open | 4.87 |
| Previous Close | 4.85 |
| Day's Range | 4.76 - 5.03 |
| 52-Week Range | 3.78 - 16.65 |
| Beta | undefined |
About OPRX
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support mes...
Sector Healthcare
IPO Date Nov 28, 2007
Employees 135
Stock Exchange NASDAQ
Ticker Symbol OPRX
Website https://www.optimizerx.com
Analyst Forecast
According to 8 analyst ratings, the average rating for OPRX stock is "Buy." The 12-month stock price forecast is $8, which is an increase of 64.61% from the latest price.
Buy 62.50%
Hold 37.50%
Sell 0.00%
Next Earnings Release
OptimizeRx Corporation is scheduled to release its earnings on Mar 27, 2025,
before market opens.
Analysts project revenue of $37.08M, reflecting a 30.56% YoY growth and earnings per share of 0.37, making a 42.31% increase YoY.
Analysts project revenue of $37.08M, reflecting a 30.56% YoY growth and earnings per share of 0.37, making a 42.31% increase YoY.
1 week ago ·
Source
-7.04%
OptimizeRx shares are trading lower after RBC Capi...
Unlock content with
Pro Subscription
2 months ago ·
Source
-33.98%
OptimizeRx shares are trading lower after JMP Securities cut its price target on the stock from $16 to $8.
